Henningfield JE
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ArticlePsilocybin
Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration.
ArticlePsychedelics
Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.
ArticlePsychedelics
Psychedelic research - Going global.
ArticlePsychedelics
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.
ArticlePsychedelics
Expanded access to psychedelic treatments: comparing American and Canadian policies.
ArticlePsilocybin
Psychedelics: Threshold of a Therapeutic Revolution.
ArticlePsilocybin
Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
ArticlePsilocybin
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.
ArticlePsilocybin
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
ArticlePsilocybin
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
ArticlePsilocybin